JB Chemicals & Pharmaceuticals Limited — Updates, 29-06-2025: Press Release

Torrent Pharma has announced a board meeting to discuss the acquisition of a 46.39% stake in J.B. Chemicals & Pharmaceuticals (JB Pharma) from KKR for INR 11,917 Cr at INR 1,600/share, followed by a mandatory open offer at INR 1,639.18/share for an additional 26% stake. Post-acquisition, Torrent plans to merge JB Pharma, offering 51 Torrent shares for every 100 JB Pharma shares. This deal boosts Torrent's presence in India’s chronic therapy market, adds new therapeutic areas like ophthalmology, and diversifies its platform with JB Pharma’s international CDMO capabilities.